SGLT2-i reduces both systolic blood pressure (SBP) and diastolic blood pressure (DBP) across multiple trials and meta-analyses with reductions up to 8.6/4.3 mmHg, depending on the agent, dose and population studied
A few things tend to help, though
Ready to Transform Your GLP-1 Journey
Verify proper injection technique and medication storage, review concurrent medications with your provider, consider comprehensive metabolic and endocrine evaluation, optimize lifestyle factors with multidisciplinary support, and discuss alternative FDA-approved obesity medications or referral for bariatric surgery evaluation if appropriate
George, we help patients from neighborhoods and communities across the region, including students at Utah Tech University, to use proven medication and physician-guided support to regain control of their health